Monoclonal antibody against gapdh

[³H]-Paclitaxel (25.7 Ci/mmol) was purchased from Moravek Biochemicals, Inc. (Brea, CA) Dulbecco modified Eagle medium (DMEM), Iscove’s DMEM, fetal bovine serum (FBS), phosphate buffer saline (PBS), 10,000 IU/ml penicillin and 10,000 μg/ml streptomycin, and trypsin 0.25% were purchased from Hyclone (Waltham, MA). Monoclonal antibody against GAPDH was purchased from Cell Signaling Technologies (Beverly, MA). Antibody D-19 against ABCC10 was obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Monoclonal antibody Ab81 against c-Kit and monoclonal antibody D12E12 against phospho-c-Kit (p-c-Kit) were obtained from Cell Signaling Technologies (Beverly, MA). Masitinib was a gift from AB Science (Paris, France). Cepharanthine was generously given by Kakenshoyaku Co. (Tokyo, Japan). PAK-104P was a gift from Nissan Chemical Industries (Tokyo, Japan). Paclitaxel, docetaxel, vincristine, vinblastine and cisplatin were purchased from Tocris Bioscience (Ellisville, MO). Boron-dipyrromethene (BODIPY) FL (fluorescent) Paclitaxel was purchased from Life technologies, Invitrogen (New York, NY). 3-(4, 5-Dimethylthiazol-yl)-2,5-diphenyltetrazolium bromide (MTT), Dimethyl sulfoxide (DMSO) and verapamil were obtained from Sigma-Aldrich Co. (St. Louis, MO).